TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,160,000 | +7206.1% | 95,222 | +7828.6% | 0.00% | – |
| Q1 2021 | $98,000 | -86.9% | 1,201 | -79.3% | 0.00% | – |
| Q4 2020 | $750,000 | +417.2% | 5,792 | +265.9% | 0.00% | – |
| Q3 2020 | $145,000 | +8.2% | 1,583 | -28.9% | 0.00% | – |
| Q2 2020 | $134,000 | -38.2% | 2,227 | -36.1% | 0.00% | – |
| Q4 2019 | $217,000 | +886.4% | 3,484 | +498.6% | 0.00% | – |
| Q3 2019 | $22,000 | -4.3% | 582 | +5.1% | 0.00% | – |
| Q2 2019 | $23,000 | – | 554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |